These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9886151)

  • 1. Intranasal immunization with Yersinia enterocolitica O:8 cellular extract protects against local challenge infection.
    Di Genaro MS; Escudero ME; Muñoz E; Aguilera C; Scardapane L; de Guzmán AM
    Microbiol Immunol; 1998; 42(11):781-8. PubMed ID: 9886151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity induced by a Yersinia enterocolitica serovar 0:8 cellular extract.
    Di Genaro MS; Escudero ME; Maccioni M; Stefanini de Guzmán AM
    Biocell; 1996 Dec; 20(3):235-41. PubMed ID: 9031590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
    Singh AK; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses.
    Baca-Estrada ME; Foldvari MM; Snider MM; Harding KK; Kournikakis BB; Babiuk LA; Griebel PP
    Vaccine; 2000 Apr; 18(21):2203-11. PubMed ID: 10717339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
    Vogel U; Autenrieth IB; Berner R; Heesemann J
    Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.
    Noll A; Bücheler N; Bohn E; Schirmbeck R; Reimann J; Autenrieth IB
    Eur J Immunol; 1999 Mar; 29(3):986-96. PubMed ID: 10092103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.
    Jiao X; Hirano T; Hou Y; Gu XX
    Infect Immun; 2002 Nov; 70(11):5982-9. PubMed ID: 12379673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit.
    Sory MP; Hermand P; Vaerman JP; Cornelis GR
    Infect Immun; 1990 Aug; 58(8):2420-8. PubMed ID: 2370100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice.
    Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E
    Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12.
    Noll A; AutenriethIB
    Infect Immun; 1996 Aug; 64(8):2955-61. PubMed ID: 8757820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral infection by Y. enterocolitica 0:8. Studies of immunization in a murine model].
    Frades MC; Díaz R
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):608-12. PubMed ID: 1822150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA; Russell MW; Cornelissen CN
    Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Combined YopB and LcrV Subunit Vaccine Elicits Protective Immunity against
    Heine SJ; Franco-Mahecha OL; Sears KT; Drachenberg CB; van Roosmalen ML; Leenhouts K; Picking WL; Pasetti MF
    J Immunol; 2019 Apr; 202(7):2005-2016. PubMed ID: 30787109
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin.
    Hotomi M; Saito T; Yamanaka N
    Vaccine; 1998 Dec; 16(20):1950-6. PubMed ID: 9796049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.